Amicus Therapeutics has opened the company’s Global Research and Gene Therapy Center of Excellence in uCity Square in Philadelphia, PA, to advance its portfolio of rare disease gene therapy programs.   In 2019, Amicus and the University of Pennsylvania announced a major expansion of their gene therapy collaboration, which provides Amicus with disease-specific worldwide rights to Penn’s next generation gene therapy technologies from the Wilson Lab for the majority of lysosomal storage disorders, ...